Edition:
United States

Chembio Diagnostics Inc (CEMI.OQ)

CEMI.OQ on NASDAQ Stock Exchange Capital Market

5.30USD
29 Mar 2017
Change (% chg)

$0.00 (+0.00%)
Prev Close
$5.30
Open
$5.30
Day's High
$5.40
Day's Low
$5.30
Volume
6,030
Avg. Vol
5,290
52-wk High
$9.32
52-wk Low
$5.05

Latest Key Developments (Source: Significant Developments)

Chembio Diagnostics Q4 loss per share $0.21
Tuesday, 7 Mar 2017 04:10pm EST 

Chembio Diagnostics Inc : Chembio diagnostics reports 2016 financial results . Q4 loss per share $0.21 .Q4 revenue fell 3.8 percent to $4.25 million.  Full Article

Chembio to acquire RVR diagnostics, establish operations in Southeast Asia
Friday, 4 Nov 2016 08:50am EDT 

Chembio Diagnostics Inc : Chembio agrees to acquire Malaysia-based RVR Diagnostics and establish operations in Southeast Asia .Chembio Diagnostics Inc - Chembio will pay up to $1.5 million in cash and up to $2 million in Chembio stock for the acquisition.  Full Article

Chembio agrees to acquire Malaysia-based RVR Diagnostics
Friday, 4 Nov 2016 12:01am EDT 

Chembio Diagnostics Inc : Chembio agrees to acquire Malaysia-based RVR Diagnostics and establish operations in Southeast Asia . Chembio will pay up to $1.5 million in cash and up to $2 million in Chembio Stock . Chembio also will forgive $250,000 currently owed by RVR to Chembio .Chembio diagnostics-to acquire RVR Diagnostics, a Malaysian, privately-held manufacturer, distributor of POC diagnostic tests for infectious diseases.  Full Article

Chembio expands exclusive distribution agreements with Isla Lab to include Puerto Rico and U.S. Virgin Islands
Friday, 23 Sep 2016 08:50am EDT 

Chembio Diagnostics Inc : Chembio expands exclusive distribution agreements with Isla Lab to include Puerto Rico and U.S. Virgin Islands . Isla Lab becomes Chembio's exclusive distribution partner throughout Caribbean region, including Puerto Rico and U.S. Virgin Islands .Entered into an exclusive distribution agreement with Isla Lab LLC that includes both Puerto Rico and U.S. Virgin Islands.  Full Article

Chembio enters into exclusive agreement with Isla Lab
Thursday, 18 Aug 2016 08:50am EDT 

Chembio Diagnostics : Chembio expands product distribution through exclusive agreement with Isla Lab in the Caribbean . Entered into agreement with Isla Lab Caribbean, which covers twenty-five nations in Caribbean, excluding Puerto Rico, U.S. Virgin Islands .Agreement with Isla Lab Caribbean initially includes co's products, which have met regulatory requirements to be sold in Caribbean region.  Full Article

Chembio Diagnostics Q2 loss per share $0.86
Thursday, 11 Aug 2016 08:50am EDT 

Chembio Diagnostics Inc : Q2 loss per share $0.86 .Q2 revenue fell 51.4 percent to $3.27 million.  Full Article

Chembio's Zika test cleared for sale in Europe and Caribbean
Wednesday, 27 Jul 2016 06:55am EDT 

Chembio Diagnostics Inc :Chembio's DPP Zika IgM/IgG assay obtains CE mark for rapid point-of-care detection of Zika virus.  Full Article

Chembio Diagnostics says proposed public offering of shares
Monday, 25 Jul 2016 08:34am EDT 

Chembio Diagnostics Inc : Chembio Diagnostics announces proposed public offering of common shares .Has commenced an underwritten public offering of $10.0 million of common shares.  Full Article

Chembio Diagnostics posts Q1 loss per share of $0.03
Thursday, 12 May 2016 08:50am EDT 

Chembio Diagnostics Inc : Chembio Diagnostics reports first quarter 2016 financial results . Q1 loss per share $0.03 .Q1 revenue rose 5.9 percent to $6.6 million.  Full Article

Chembio Diagnostics, Inc to collaborate with Bio-Manguinhos/to develop Zika Diagnostic Tests
Monday, 7 Mar 2016 08:50am EST 

Chembio Diagnostics, Inc:To collaborate with bio-manguinhos/fiocruz to develop point-of-care zika diagnostic tests for Brazil.Says plans to collaborate with bio-manguinhos/fiocruz for the development of poc zika diagnostic tests for Brazil.Says Chembio will add zika to the poc dpp fever panel assay that is currently under development.  Full Article

More From Around the Web

BRIEF-Chembio Diagnostics Q4 loss per share $0.21

* Q4 revenue fell 3.8 percent to $4.25 million Source text for Eikon: Further company coverage: